LexaGene Holdings (CVE: LXG – OTCQB: LXXGF) CEO Dr. Jack Regan joined Steve Darling from Proactive to share news the company has announced the release of a news test panel within the MiQLab testing unit.
Regan telling Proactive, the next-generation test panel will screen for 10 pathogens and 30 gene variants. The new panel is expected to detect 96% of bacterial UTIs & 93% of bacterial SSTI’s and pick up a much higher percentage of genes that confer resistance to some of the most commonly prescribed antibiotics.